Premium
Identification of influence of CYP3A5 genetic polymorphism in tacrolimus pharmacokinetics assessed from routine TDM data using population pharmacokinetic approach
Author(s) -
Kim J.,
Chung J.,
Cho J.,
Lim H.,
Hong K.,
Oh D.,
Yi S.,
Jang I.,
Shin S.
Publication year - 2003
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1016/s0009-9236(03)90430-9
Subject(s) - pharmacokinetics , cyp3a5 , tacrolimus , population pharmacokinetics , medicine , pharmacogenetics , pharmacology , population , biology , genotype , genetics , transplantation , environmental health , gene
Clinical Pharmacology & Therapeutics (2003) 73 , P20–P20; doi: